Our observations did not support the hypothesis of SB supplementation reducing the incidence of AKI in this environment, as there were no meaningful differences or changes from pre‐ to post‐work in urinary NGAL, TIMP2, or IGFBP‐7 concentrations despite inducing a significant state of metabolic alkalosis in the SB condition. The gene discussed is LCN2; the disease is acute kidney injury.